{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T22:20:57Z","timestamp":1776723657273,"version":"3.51.2"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T00:00:00Z","timestamp":1770336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T00:00:00Z","timestamp":1773360000000},"content-version":"vor","delay-in-days":35,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004622","name":"KWF Kankerbestrijding","doi-asserted-by":"publisher","award":["KUN 2019-12640"],"award-info":[{"award-number":["KUN 2019-12640"]}],"id":[{"id":"10.13039\/501100004622","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-026-15668-1","type":"journal-article","created":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T00:43:51Z","timestamp":1770338631000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Patients with tumor deposits benefit equally from adjuvant therapy compared to other stage III colon cancer groups: two retrospective population-based studies"],"prefix":"10.1186","volume":"26","author":[{"given":"Ayse Selcen Oguz","family":"Erdogan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yao","family":"Shu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elske","family":"Gootjes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Femke","family":"Simmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iris D.","family":"Nagtegaal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,6]]},"reference":[{"key":"15668_CR1","unstructured":"American Joint Committee on Cancer. Manual for Staging of Cancer. 7th ed. New York, NY: Springer. 2010. https:\/\/cancerstaging.org. Accessed 11 Mar 2024."},{"key":"15668_CR2","unstructured":"WHO Classification of Tumours Editorial Board. Digestive Systems Tumours, WHO Classification of Tumours, 5th edition. 2019."},{"issue":"63","key":"15668_CR3","doi-asserted-by":"publisher","first-page":"303","DOI":"10.2340\/1651-226X.2024.35232","volume":"7","author":"G Engholm","year":"2024","unstructured":"Engholm G, Lundberg FE, K\u00f8nig SM, \u00d3lafsd\u00f3ttir E, Johannesen TB, Pettersson D, et al. TNM stage in the nordic cancer registries 2004\u20132016: registration and availability. Acta Oncol. 2024;7(63):303\u201312. https:\/\/doi.org\/10.2340\/1651-226X.2024.35232.\u00a0","journal-title":"Acta Oncol"},{"issue":"12","key":"15668_CR4","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1038\/s41571-019-0253-x","volume":"16","author":"J Brierley","year":"2019","unstructured":"Brierley J, O\u2019Sullivan B, Asamura H, Byrd D, Huang SH, Lee A, et al. Global consultation on cancer staging: promoting consistent understanding and use. Nat Rev Clin Oncol. 2019;16(12):763\u201371. https:\/\/doi.org\/10.1038\/s41571-019-0253-x.","journal-title":"Nat Rev Clin Oncol."},{"key":"15668_CR5","doi-asserted-by":"publisher","DOI":"10.1002\/cac2.12598","author":"NPM Brouwer","year":"2024","unstructured":"Brouwer NPM, Oguz Erdogan AS, van Vliet S, Rutgers N, Knijn N, van Lijnschoten G, et al. Unraveling the routes to distant metastases in colorectal cancer: tumor deposits and lymph node metastases as the gateway. Cancer Commun. 2024. https:\/\/doi.org\/10.1002\/cac2.12598.","journal-title":"Cancer Commun"},{"issue":"12","key":"15668_CR6","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1016\/S1470-2045(20)30527-1","volume":"21","author":"T Andr\u00e9","year":"2020","unstructured":"Andr\u00e9 T, Meyerhardt J, Iveson T, Sobrero A, Yoshino T, Souglakos I, et al. Effect of duration of adjuvant chemotherapy for patients with stage III colon cancer (IDEA collaboration): final results from a prospective, pooled analysis of six randomised, phase 3 trials. Lancet Oncol. 2020;21(12):1620\u20139. https:\/\/doi.org\/10.1016\/S1470-2045(20)30527-1.\u00a0","journal-title":"Lancet Oncol"},{"key":"15668_CR7","doi-asserted-by":"publisher","first-page":"102325","DOI":"10.1016\/j.ctrv.2021.102325","volume":"103","author":"JF Delattre","year":"2022","unstructured":"Delattre JF, Selcen Oguz Erdogan A, Cohen R, Shi Q, Emile JF, Taieb J, et al. A comprehensive overview of tumour deposits in colorectal cancer: towards a next TNM classification. Cancer Treat Rev. 2022;103:102325. https:\/\/doi.org\/10.1016\/j.ctrv.2021.102325.\u00a0","journal-title":"Cancer Treat Rev"},{"issue":"10","key":"15668_CR8","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1200\/JCO.2016.68.9091","volume":"35","author":"ID Nagtegaal","year":"2017","unstructured":"Nagtegaal ID, Knijn N, Hugen N, Marshall HC, Sugihara K, Tot T, et al. Tumor deposits in colorectal cancer: improving the value of modern staging-a systematic review and meta-analysis. J Clin Oncol. 2017;35(10):1119\u201327. https:\/\/doi.org\/10.1200\/JCO.2016.68.9091.\u00a0","journal-title":"J Clin Oncol"},{"issue":"3","key":"15668_CR9","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1111\/codi.16873","volume":"26","author":"L Hakki","year":"2024","unstructured":"Hakki L, Khan A, Do E, Gonen M, Firat C, Vakiani E, et al. Tumour deposits are independently associated with recurrence in colon cancer. Colorectal Dis. 2024;26(3):459\u201365. https:\/\/doi.org\/10.1111\/codi.16873.\u00a0","journal-title":"Colorectal Dis"},{"issue":"6","key":"15668_CR10","doi-asserted-by":"publisher","first-page":"zrad122","DOI":"10.1093\/bjsopen\/zrad122","volume":"7","author":"F J\u00f6rgren","year":"2023","unstructured":"J\u00f6rgren F, Agger E, Lydrup ML, Buchwald P. Tumour deposits in colon cancer predict recurrence and reduced survival in a nationwide population-based study. BJS Open. 2023;7(6):zrad122. https:\/\/doi.org\/10.1093\/bjsopen\/zrad122.\u00a0","journal-title":"BJS Open"},{"issue":"4","key":"15668_CR11","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1016\/S1470-2045(18)30093-7","volume":"19","author":"TJ Iveson","year":"2018","unstructured":"Iveson TJ, Kerr RS, Saunders MP, Cassidy J, Hollander NH, Tabernero J, et al. 3 versus 6 months of adjuvant oxaliplatin-fluoropyrimidine combination therapy for colorectal cancer (SCOT): an international, randomised, phase 3, non-inferiority trial. Lancet Oncol. 2018;19(4):562\u201378. https:\/\/doi.org\/10.1016\/S1470-2045(18)30093-7.\u00a0","journal-title":"Lancet Oncol"},{"issue":"10","key":"15668_CR12","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1016\/j.annonc.2020.06.022","volume":"31","author":"G Argil\u00e9s","year":"2020","unstructured":"Argil\u00e9s G, Tabernero J, Labianca R, Hochhauser D, Salazar R, Iveson T, et al. Localised colon cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2020;31(10):1291\u2013305. https:\/\/doi.org\/10.1016\/j.annonc.2020.06.022.\u00a0","journal-title":"Ann Oncol"},{"issue":"2","key":"15668_CR13","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1111\/his.14344","volume":"79","author":"A Lord","year":"2021","unstructured":"Lord A, Brown G, Abulafi M, Bateman A, Frankel W, Goldin R, et al. Histopathological diagnosis of tumour deposits in colorectal cancer: a delphi consensus study. Histopathology. 2021;79(2):168\u201375. https:\/\/doi.org\/10.1111\/his.14344.\u00a0","journal-title":"Histopathology"},{"key":"15668_CR14","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.ijsu.2018.06.029","volume":"56","author":"X Li","year":"2018","unstructured":"Li X, An B, Zhao Q, Qi J, Wang W, Zhang D, et al. Impact of tumor deposits on the prognosis and chemotherapy efficacy in stage III colorectal cancer patients with different lymph node status: a retrospective cohort study in China. Int J Surg. 2018;56:188\u201394. https:\/\/doi.org\/10.1016\/j.ijsu.2018.06.029.","journal-title":"Int J Surg"},{"issue":"1","key":"15668_CR15","doi-asserted-by":"publisher","first-page":"16909","DOI":"10.1038\/s41598-022-21331-z","volume":"12","author":"S Liu","year":"2022","unstructured":"Liu S, Lin Y, Huang S, Xue S, Huang R, Chen L, et al. Identifying the long-term survival beneficiary of chemotherapy for stage N1c sigmoid colon cancer. Sci Rep. 2022;12(1):16909. https:\/\/doi.org\/10.1038\/s41598-022-21331-z.\u00a0","journal-title":"Sci Rep"},{"issue":"10","key":"15668_CR16","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1016\/j.annonc.2021.07.009","volume":"32","author":"R Cohen","year":"2021","unstructured":"Cohen R, Shi Q, Meyers J, Jin Z, Svrcek M, Fuchs C, et al. Combining tumor deposits with the number of lymph node metastases to improve the prognostic accuracy in stage III colon cancer: a post hoc analysis of the CALGB\/SWOG 80702 phase III study (Alliance)\u2606. Ann Oncol. 2021;32(10):1267\u201375. https:\/\/doi.org\/10.1016\/j.annonc.2021.07.009.\u00a0","journal-title":"Ann Oncol"},{"issue":"1","key":"15668_CR17","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1155\/2007\/971816","volume":"29","author":"M Casparie","year":"2007","unstructured":"Casparie M, Tiebosch AT, Burger G, Blauwgeers H, van de Pol A, van Krieken JH, et al. Pathology databanking and biobanking in The Netherlands, a central role for PALGA, the nationwide histopathology and cytopathology data network and archive. Cell Oncol. 2007;29(1):19\u201324. https:\/\/doi.org\/10.1155\/2007\/971816.\u00a0","journal-title":"Cell Oncol"},{"key":"15668_CR18","unstructured":"Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) SEER*Stat Database: Incidence - SEER Research Data, 17 Registries, Nov 2023 Sub (2000\u20132021) - Linked To County Attributes - Time Dependent (1990\u20132022) Income\/Rurality, 1969\u20132022 Counties, National Cancer Institute, DCCPS, Surveillance Research Program, released April 2024, based on the November 2023 submission."},{"issue":"0 0","key":"15668_CR19","doi-asserted-by":"publisher","first-page":"3793","DOI":"10.1002\/cncr.29056","volume":"120 Suppl 23","author":"VW Chen","year":"2014","unstructured":"Chen VW, Hsieh MC, Charlton ME, Ruiz BA, Karlitz J, Altekruse SF, et al. Analysis of stage and clinical\/prognostic factors for colon and rectal cancer from SEER registries: AJCC and collaborative stage data collection system. Cancer. 2014;120 Suppl 23(0 0):3793\u2013806. https:\/\/doi.org\/10.1002\/cncr.29056.\u00a0","journal-title":"Cancer"},{"key":"15668_CR20","unstructured":"National Cancer Institute. Treatment limitations. SEER Stat. 2022. https:\/\/seer.cancer.gov\/data-software\/documentation\/seerstat\/nov2022\/treatment-limitations-nov2022.html."},{"issue":"4","key":"15668_CR21","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.currproblcancer.2012.03.011","volume":"36","author":"HS Park","year":"2012","unstructured":"Park HS, Lloyd S, Decker RH, Wilson LD, Yu JB. Limitations and biases of the surveillance, epidemiology, and end results database. Curr Probl Cancer. 2012;36(4):216\u201324. https:\/\/doi.org\/10.1016\/j.currproblcancer.2012.03.011.\u00a0","journal-title":"Curr Probl Cancer"},{"issue":"11","key":"15668_CR22","doi-asserted-by":"publisher","first-page":"3179","DOI":"10.1245\/s10434-018-6661-9","volume":"25","author":"KA Mirkin","year":"2018","unstructured":"Mirkin KA, Kulaylat AS, Hollenbeak CS, Messaris E. Prognostic significance of tumor deposits in stage III colon cancer. Ann Surg Oncol. 2018;25(11):3179\u201384. https:\/\/doi.org\/10.1245\/s10434-018-6661-9.\u00a0","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"15668_CR23","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1097\/COC.0000000000000645","volume":"43","author":"VE Pricolo","year":"2020","unstructured":"Pricolo VE, Steingrimsson J, McDuffie TJ, McHale JM, McMillen B, Shparber M. Tumor deposits in stage iii colon cancer: correlation with other histopathologic variables, prognostic value, and risk stratification-time to consider \u201cN2c.\u201d Am J Clin Oncol. 2020;43(2):133\u20138. https:\/\/doi.org\/10.1097\/COC.0000000000000645.\u00a0","journal-title":"Am J Clin Oncol"},{"issue":"9","key":"15668_CR24","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1097\/DCR.0000000000001152","volume":"61","author":"N Wong-Chong","year":"2018","unstructured":"Wong-Chong N, Motl J, Hwang G, Nassif GJ Jr, Albert MR, Monson JRT, et al. Impact of tumor deposits on oncologic outcomes in stage III colon cancer. Dis Colon Rectum. 2018;61(9):1043\u201352. https:\/\/doi.org\/10.1097\/DCR.0000000000001152.\u00a0","journal-title":"Dis Colon Rectum"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-026-15668-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-15668-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-15668-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T11:21:35Z","timestamp":1773400895000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12885-026-15668-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,6]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["15668"],"URL":"https:\/\/doi.org\/10.1186\/s12885-026-15668-1","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,6]]},"assertion":[{"value":"17 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki and Dutch \"Federa, Human Tissue and Medical Research: Code of Conduct for responsible use (2011)\" guideline. The Dutch cohort was approved by the scientific committees of NCR and PALGA. Registration numbers are K23.281 and LZV2019-91, respectively. SEER-research data is publicly accessible database. Consent to participate is not applicable for this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"346"}}